European Union
International Standa...
NGOs
United Nations
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde Islands
Central African Republic
Chad
Comoros
Congo (Brazzaville)
Congo, Democratic Re...
Cote d'Ivoire
Djibouti
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mayotte
Morocco
Mozambique
Namibia
Niger
Nigeria
Reunion
Rwanda
Sao Tome & Principe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
St. Helena
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Western Sahara
Zambia
Zimbabwe
|
TanzaniaInstitute for Occupational Medicine (IOM)
| Report Title: |
EMERGNANO: a Review of Completed and Near Completed Environment, Health and Safety Research on Nanomaterials and Nanotechnology |
| Report ID: |
466 |
| Date: |
3/1/2009 |
| Author: |
RJ Aitken, SM Hankin, B Ross, et al |
| Report Type: |
Research Report |
| URL: |
[Document.aspx] |
| Country: |
United Kingdom |
| Organization: |
Institute for Occupational Medicine (IOM) |
| Summary: |
After the Royal Society and Royal Academy of Engineering's 2004 report (see report ID 446) on opportunities and uncertainties in nanotechnology, the UK set up the Nanotechnology Research Coordination Group to coordinate publicly funded research into the risks of nanotechnology. Under the guidance of Defra, this report was commissioned to review and analyze the state of research in 18 research objectives set out in Defra's 2006 first research progress report. This report also assesses the possibility of a qualitative risk assessment and makes recommendations for new research to fill gaps. Research studies were categorized by their relation to one or more of the research objectives. The study finds that there is a widespread imbalance in the work carried out between the research objectives. While 44 studies were relevant to RO14 (Research Objective 14 – research to establish a clear understanding of the deposition, distribution, toxicity, pathogenicity, and translocation potential and pathways for nanoparticles in the airways and lung and their potential impacts on the cardiovascular system and brain), only one study was relevant to RO9 (optimization, development, and application of technologies that enable the measurement of exposure to nanoparticles in soil and water). Many of the studies, although publicly funded, had not released any information into the public domain. A total of 260 relevant studies worldwide were identified in this report, and analysis so far shows that three nanomaterials are cause for concern: carbon nanotubes, silver nanoparticles, and titanium dioxide nanoparticles. |
| Archived Copy: |
CB0409_7911_FRP_466_1948.pdf |
 |
|
| Report Title: |
An Outline Scoping Study to Determine Whether High Aspect Ratio Nanoparticles (harn) Should Raise the Same Concerns as Do Asbestos Fibres |
| Report ID: |
182 |
| Date: |
8/13/2008 |
| Author: |
CL Tran, SM Hankin, B Ross, RJ Aitken, AD Jones, |
| Report Type: |
Research Report |
| URL: |
[Document.aspx] |
| Country: |
United Kingdom |
| Organization: |
Institute for Occupational Medicine (IOM) |
| Summary: |
The similar size and shape of certain nanoparticles, particularly carbon nanotubes, to asbestos fibers has created significant concern because of the well-publicized risks of asbestos towards human health. This study seeks to review existing literature on whether high aspect ratio nanoparticles (HARN) should generate the same concerns as do asbestos fibers. It also establishes a research strategy for the determination of specific health risks posed by HARN. Three fiber characteristics are likely to cause asbestos-like injuries: diameter, length, and biopersistence. The review concludes that HARN are similar enough in these characteristics as to pose similar health risks. The proposed strategy for examining these risks is composed of stages of hazard identification, dose-response assessment, exposure assessment, and risk assessment. The report makes a list of prioritized recommendations for further studies, both in vivo and in vitro, of these areas. |
| Archived Copy: |
Michael Vincent IOM (2008), An outline scoping study_182_2184.pdf |
|
|
|